1. Home
  2. IHRT vs DCTH Comparison

IHRT vs DCTH Comparison

Compare IHRT & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iHeartMedia Inc.

IHRT

iHeartMedia Inc.

HOLD

Current Price

$4.50

Market Cap

711.8M

ML Signal

HOLD

Logo Delcath Systems Inc.

DCTH

Delcath Systems Inc.

HOLD

Current Price

$10.08

Market Cap

350.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IHRT
DCTH
Founded
1974
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
711.8M
350.7M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
IHRT
DCTH
Price
$4.50
$10.08
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$4.50
$22.60
AVG Volume (30 Days)
1.3M
596.1K
Earning Date
11-10-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.03
Revenue
$3,856,033,000.00
$79,603,000.00
Revenue This Year
$1.96
$131.97
Revenue Next Year
$5.62
$38.84
P/E Ratio
N/A
$291.69
Revenue Growth
1.39
251.54
52 Week Low
$0.95
$8.12
52 Week High
$5.44
$18.23

Technical Indicators

Market Signals
Indicator
IHRT
DCTH
Relative Strength Index (RSI) 56.94 56.71
Support Level $4.31 $9.84
Resistance Level $4.74 $10.44
Average True Range (ATR) 0.38 0.43
MACD 0.00 0.03
Stochastic Oscillator 47.81 49.07

Price Performance

Historical Comparison
IHRT
DCTH

About IHRT iHeartMedia Inc.

iHeartMedia Inc is a United States-based audio media company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: